心律調節器市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球心律調節器市場價值為 57 億美元，預計將以 4.8% 的複合年成長率成長，到 2034 年達到 90 億美元。

這一強勁成長的動力源於心血管疾病發病率的上升、支持性報銷政策以及人們對微創手術日益成長的偏好。心律調節器在管理心律不整方面發揮著至關重要的作用，它在心臟自然傳導系統出現問題時發出電脈衝來調節心跳。美敦力、雅培和波士頓科學等行業領導者走在前列，憑藉先進的設計、更長的電池壽命和遠端監控功能推動創新。相容於核磁共振成像（MRI）的心律調節器越來越受歡迎，使患者能夠在植入後安全地進行核磁共振成像——這對於診斷其他健康狀況至關重要。此外，支援藍牙和人工智慧的心律調節器的推出正在改變心臟護理，它允許即時遠端監控，將急診就診次數減少高達 30%，並允許臨床醫生根據患者活動和心律模式客製化設備設定。電池技術的改進顯著延長了心律調節器的使用壽命，許多現代設備的使用壽命長達 20 年，最大限度地減少了頻繁更換心律調節器的需要。

2024年，植入式心律調節器市場佔據了89.1%的市場佔有率，因其在治療心動過緩和心律不整等慢性心律不整方面已被證實的有效性而備受青睞。這些設備提供持續起搏，改善患者預後，並因其微創植入技術而被廣泛採用。其可編程性使醫療保健提供者能夠根據個別患者需求量身設置，確保最佳的心臟護理，尤其適用於老齡化人群和復發性心律不整患者。

雙腔心律調節器市場規模達41億美元，預計2025-2034年期間的複合年成長率將達到5.2%，這得益於越來越多的房室傳導阻滯患者受益於雙腔心律調節器。這些心律調節器在右心房和右心室分別放置兩根導線，它們協同工作，模擬心房和心室收縮的自然時間。這種同步性可以改善血流和心輸出量，從而更好地向身體組織和器官輸送氧氣。

2024年，北美心律調節器市場佔據50.9%的市場佔有率，這得益於主要市場參與者的加入、心血管設備需求的不斷成長以及心臟病患病率的不斷上升。心血管疾病導致的住院人數增加進一步刺激了對心律調節器及相關監測設備的需求。該地區也受益於專注於提升心律調節器技術的強勁研發活動，推動了市場的持續擴張。預計新公司的進入將在整個預測期內加速市場成長。

全球心律調節器產業的知名公司包括波士頓科學、百多力、樂普醫療、MEDICO、美敦力、雅培、微創醫療、Oscor、Osypka Medical、Pacetronix 和 Vitatron。為了鞏固市場地位，心律調節器產業的領先公司高度重視創新，開發電池壽命更長、成像技術相容性更強、遠端監控功能更強大的設備。許多公司正在投資人工智慧和藍牙技術，以提供即時資料傳輸和個人化患者護理。擴大地域覆蓋，尤其是新興市場，是另一個關鍵策略，並輔以與醫療服務提供者的合作和政府專案的支持。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 心血管疾病盛行率不斷上升
    • 優惠的報銷政策
    • 技術進步
    • 微創手術的採用率不斷上升
  • 產業陷阱與挑戰
    • 心律調節器裝置和植入費用高昂
    • 嚴格的法規核准
  • 市場機會
    • MRI相容心律調節器的需求不斷成長
    • 遠端監控和遠端心臟病學解決方案的整合
• 成長潛力分析
• 監管格局
• 技術格局
  • 現有技術
  • 新興技術
• 未來市場趨勢
• 報銷場景
• 品牌分析
• 管道分析
• 投資前景
• 啟動場景
• 2021-2024 年各地區心律調節器數量
• 2024年定價分析
• 波特的分析
• PESTEL分析
• 差距分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲和中東地區
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 植入式心律調節器
• 體外心律調節器

第6章：市場估計與預測：按技術，2021 - 2034 年

• 主要趨勢
• 單腔心律調節器
  • 單腔心室
  • 單腔心房
• 雙腔心律調節器
• 雙心室/CRT心律調節器

第7章：市場估計與預測：按應用，2021 - 2034

• 主要趨勢
• 充血性心臟衰竭
• 心搏過緩
• 心律不整
• 心跳過速
• 其他應用

第8章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院和診所
• 心臟護理中心
• 門診手術中心
• 其他最終用途

第9章：市場估計與預測：按地區，2021 - 2034

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Abbott
• BIOTRONIK
• Boston Scientific
• Lepu Medical
• MEDICO
• Medtronic
• MicroPort
• Oscor
• Osypka Medical
• Pacetronix
• Vitatron

The Global Pacemakers Market was valued at USD 5.7 billion in 2024 and is estimated to grow at a CAGR of 4.8% to reach USD 9 billion by 2034.

This robust growth is driven by the rising incidence of cardiovascular diseases, supportive reimbursement policies, and the increasing preference for minimally invasive procedures. Pacemakers play a vital role in managing heart rhythm disorders by delivering electrical impulses that regulate the heartbeat when the heart's natural conduction system falters. Industry leaders such as Medtronic, Abbott, and Boston Scientific are at the forefront, pushing innovation with advanced designs, extended battery life, and remote monitoring capabilities. MRI-compatible pacemakers have become increasingly popular, enabling patients to safely undergo magnetic resonance imaging after implantation-a crucial development for diagnosing other health conditions. Moreover, the introduction of Bluetooth-enabled and AI-powered pacemakers is transforming cardiac care by allowing real-time remote monitoring, reducing emergency hospital visits by up to 30%, and letting clinicians customize device settings based on patient activity and heart rhythm patterns. The battery technology improvements have significantly extended pacemaker longevity, with many modern devices lasting up to 20 years, minimizing the need for frequent replacements.

The implantable pacemakers segment held 89.1% share in 2024, favored for their proven effectiveness in treating chronic heart rhythm conditions such as bradycardia and arrhythmias. These devices offer continuous pacing, enhanced patient outcomes, and are widely adopted due to minimally invasive implantation techniques. Their programmability allows healthcare providers to tailor settings to individual patient needs, ensuring optimal cardiac care, especially for aging populations and those with recurrent rhythm issues.

The dual-chamber pacemakers segment generated USD 4.1 billion and is expected to grow at a CAGR of 5.2% during 2025-2034, attributed to the increasing number of patients suffering from atrioventricular block who benefit from dual-chamber devices. These pacemakers have two leads positioned in the right atrium and right ventricle, which work together to replicate the natural timing of atrial and ventricular contractions. This synchronization improves blood flow and cardiac output, leading to better oxygen delivery to the body's tissues and organs.

North America Pacemakers Market held 50.9% share in 2024, driven by the presence of key market players, rising demand for cardiovascular devices, and a growing prevalence of heart conditions. Increased hospital admissions due to cardiovascular issues further boost the demand for pacemakers and related monitoring devices. The region also benefits from strong R&D activities focused on enhancing pacemaker technologies, fueling continued market expansion. The entry of new companies into the market is expected to accelerate growth throughout the forecast period.

Prominent companies in the Global Pacemakers Industry include Boston Scientific, BIOTRONIK, Lepu Medical, MEDICO, Medtronic, Abbott, MicroPort, Oscor, Osypka Medical, Pacetronix, and Vitatron. To strengthen their market position, leading companies in the pacemakers sector focus heavily on innovation, developing devices with longer battery lives, improved compatibility with imaging technologies, and enhanced remote monitoring capabilities. Many firms are investing in AI and Bluetooth technologies to offer real-time data transmission and personalized patient care. Expanding geographic presence, especially into emerging markets, is another key strategy, supported by partnerships with healthcare providers and government programs.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Technology trends
  • 2.2.4 Application trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular diseases
    • 3.2.1.2 Favorable reimbursement policies
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Rising adoption of minimally invasive procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of pacemaker devices and implantation
    • 3.2.2.2 Stringent regulatory approvals
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rising demand for MRI-compatible pacemakers
    • 3.2.3.2 Integration of remote monitoring and telecardiology solutions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
  • 3.5.1 Current technologies
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Reimbursement scenario
• 3.8 Brand analysis
• 3.9 Pipeline analysis
• 3.10 Investment landscape
• 3.11 Start-up scenario
• 3.12 Number of pacemaker units, by region, 2021-2024
  • 3.12.1 North America
  • 3.12.2 Europe
  • 3.12.3 Asia Pacific
  • 3.12.4 Latin America
  • 3.12.5 MEA
• 3.13 Pricing analysis, 2024
• 3.14 Porter's analysis
• 3.15 PESTEL analysis
• 3.16 Gap analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 North America
  • 4.3.2 Europe
  • 4.3.3 Asia Pacific
  • 4.3.4 LAMEA
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Implantable pacemakers
• 5.3 External pacemakers

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Single-chamber pacemakers
  • 6.2.1 Single-chamber ventricular
  • 6.2.2 Single-chamber atrial
• 6.3 Dual-chamber pacemakers
• 6.4 Biventricular/CRT pacemakers

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Congestive heart failure
• 7.3 Bradycardia
• 7.4 Arrhythmias
• 7.5 Tachycardia
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Cardiac care centers
• 8.4 Ambulatory surgical centers
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Abbott
• 10.2 BIOTRONIK
• 10.3 Boston Scientific
• 10.4 Lepu Medical
• 10.5 MEDICO
• 10.6 Medtronic
• 10.7 MicroPort
• 10.8 Oscor
• 10.9 Osypka Medical
• 10.10 Pacetronix
• 10.11 Vitatron